Literature DB >> 9313967

The course of psoriasis.

E M de Jong1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9313967     DOI： 10.1016/s0738-081x(97)00023-0

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  5 in total

1.  Equivalence and measurement properties of an electronic version of the Psoriasis Symptom Inventory.

Authors:  Donald M Bushnell; Mona L Martin; Michael Scanlon; Techieh Chen; Dina Chau; Hema N Viswanathan
Journal:  Qual Life Res       Date:  2013-09-20       Impact factor: 4.147

Review 2.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.

Authors:  Kim A Papp; James Signorovitch; Karthik Ramakrishnan; Andrew P Yu; Shiraz R Gupta; Yanjun Bao; Parvez M Mulani
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

4.  Psoriasis exacerbation after hormonotherapy in prostate cancer patient-Case report.

Authors:  Ewa Ziółkowska; Marta Biedka; Agnieszka Zyromska; Roman Makarewicz
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-06

5.  Long-term Outcomes and Prognosis in New-Onset Psoriasis.

Authors:  Axel Svedbom; Lotus Mallbris; Per Larsson; Pernilla Nikamo; Katarina Wolk; Petra Kjellman; Enikö Sonkoly; Liv Eidsmo; Ulla Lindqvist; Mona Ståhle
Journal:  JAMA Dermatol       Date:  2021-04-14       Impact factor: 10.282
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.